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Polyomaviruses induce tumors of different histological types when inoculated into experimental animals. An etiological
role for this virus group in the development of malignant tumors in humans remains questionable, despite several reports
demonstrating the presence of SV40, JCV, and BKV DNA in human cancers. Only two human polyomavirus types are known
to date: JCV, causing progressive multifocal leukoencephalopathy (PML) under severe immunosuppression, and BKV, first
isolated from the urine of a renal transplant recipient and associated with hemorrhagic cystitis. We developed a degenerate
polymerase chain reaction assay in an attempt to identify additional, presently unknown human polyomavirus types that
may be involved in the malignant transformation of human tissues. A large part of the gene coding for the viral capsid
protein VP1 is highly conserved in nine polyomavirus types (and their strains) and was therefore selected as most suitable
for the primer design. Degenerate oligonucleotide primers were deduced from four different conserved amino acid motifs
in this region. Three different sets of primers were included in each test to obtain the highest sensitivity in combination
with primers with the lowest degeneracy numbers. The sensitivity obtained ranged from 1 copy/cell for bovine polyomavirus
to 100 copies/cell for LPV after ethidium bromide staining and was increased at least 10-fold after hybridization with a
radiolabeled probe. A subsequent seminested amplification allowed for the detection of 1 copy/cell for LPV. These degener-
ate primers were applied to analyze bladder carcinomas, Hodgkin lymphomas, meningiomas, Kaposi tumors, and Kaposi-
derived cell lines. No polyomavirus DNA sequences could be detected. q 1997 Academic Press
the urine of such patients after immunosuppression fol-INTRODUCTION
lowing organ transplantation (Lecatsas et al., 1973).
Inoculation of tissue extracts containing the mouse poly-The polyomavirus family comprises 12 different poly-
omavirus induced parotid carcinomas in newborn miceomavirus types infecting animals and humans. The bud-
(Gross, 1953), whereas the DNA from skin epitheliomas ingerigar fledgling disease virus (BFDV) causes a multisys-
hamsters induced lymphomas and leukemias when inocu-temic fatal infection in its natural host (Bozeman et al.,
lated into these hosts (Graffi et al., 1967). Experimental1981), whereas the hamster polyomavirus (HaPV) in-
transmission of the other polyomaviruses results in a spec-duces skin epitheliomas and lymphomas (Graffi et al.,
trum of diseases depending on the virus type used and1967). Primary infections by the other polyomaviruses
the site of inoculation. The most frequent tumors producedappear to progress subclinically, followed by a lifelong
by BKV in Syrian hamsters are ependymomas, choroidpersistence of the virus. Immunosuppression may lead to
plexus papillomas, pancreatic islet tumors, and osteosar-reactivation which often results in overt disease. Human
comas (Corallini et al., 1978). Transgenic mice containingpolyomavirus JCV causes progressive multifocal leu-
a single copy of BKV developed renal adenocarcinomaskoencephalopathy (PML) in immunocompromised pa-
and extremely enlarged thymuses (Dalrymple and Bee-tients (Padgett et al., 1971). The immunological impair-
mon, 1990). Brain and bone tumors, as well as lymphomasment following simian immunodeficiency virus (SIV) in-
and mesotheliomas, develop in hamsters after infectionfection of macaque monkeys leads to simian virus 40
with SV40 (Diamandopoulos et al., 1973; Gerber and(SV40)-induced PML in adult animals (Horvarth et al.,
Kirchstein, 1962). JCV induces mainly brain tumors, not1992) and severe bilateral tubulointerstitial nephritis in
only in rodents, but also in owls and squirrel monkeysjuvenile animals (Ilyinskii et al., 1992). The other human
(London et al., 1978; Houff et al., 1983).polyomavirus, BKV, is associated with hemorrhagic cysti-
The etiological role of polyomaviruses in naturally oc-tis in bone marrow transplant patients (Arthur et al.,
curring human tumors remains unclear. BKV DNA has1986), whereas viral particles can be demonstrated in
been detected in a variety of lesions. Extrachromosomal
BKV DNA was demonstrated in a pancreatic B-islet ade-
noma (Caputo et al., 1983). The majority of subsequent1 To whom reprint requests should be addressed. Fax: 49–6221–
424822. reports used polymerase chain reaction (PCR) to detect
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the presence of viral DNA in a broad spectrum of tumors. sequences: JCV (Frisque et al., 1984), BKV-AS strain
(Tavis et al., 1989) and BKV-Dunlop strain (Seif et al.,BKV DNA was present in osteosarcomas (6/12) and brain
tumors (50/58) (de Mattei et al., 1995), Kaposi tumors (38/ 1981), SV40 (Fiers et al., 1978), bovine polyomavirus
(Schuurman et al., 1990), HaPV (Delmas et al., 1985), LPV38) and cell lines (6/8), cervical and vulvar neoplasias
(32/42), and prostate adenocarcinomas (4/7) (Monini et (Pawlita et al., 1985), BFDV (Rott et al., 1988), Kilham
polyomavirus (Mayer and Do¨rries, 1991), and mouseal., 1996), but Arthur et al. (1994) failed to demonstrate
these viral sequences in 75 malignant gliomas. A similar polyomavirus strain a2 (Soeda and Griffin, 1978), strain
a3 (Deininger et al., 1980), and the Crawford strain (Roth-pattern has been published for SV40 DNA in human tu-
mors. After initial reports of SV40 DNA in a metastatic well and Folk, 1983). These sequences were obtained
from the EMBL Databank. Comparative analyses weremelanoma (Soriano et al., 1974) and from two brains of
patients with PML (Weiner et al., 1972), recent studies done with the HUSAR software package (Deutsches
Krebsforschungsinstitut and Center of Molecular Biology,detected SV40 DNA in ependymomas (10/11), choroid
plexus neoplasms (10/20) (Bergsagel et al., 1992; Led- University of Heidelberg). Seven different primers of 17
nucleotides each were selected (Table 1) and the oligo-nicky et al., 1995), mesotheliomas (29/48) (Carbone et
al., 1994), and a variety of bone tumors (54/160) (Carbone nucleotides synthesized tailed with a BamHI linker at
the 5* end. A phylogenetic tree of the sequences waset al., 1996). In contrast, Strickler et al. (1996) failed to
detect SV40 sequences in 48 mesotheliomas tested. JCV constructed using the CLUSTAL program available in the
HUSAR software package.DNA has been demonstrated in a single case of oligoas-
trocytoma (Rencic et al., 1996).
BKV and JCV are the only representatives of human PCR amplification
polyomaviruses known to date and seroepidemiological
The reaction mixture consisted of 50–100 ng of cellularstudies have demonstrated the presence of antibodies
DNA, 50 pmol each of the forward and backward primers,against these viruses in 70% of the adult population
0.2 mM dNTPs, 1.5 mM MgCl2 , 1 U Taq polymerase, and(Shah et al., 1972). In addition, 30% of adults above the
PCR buffer provided by the manufacturer (Gibco BRL).age of 30 years reacted seropositive against the antigen
Conditions used for amplification were as follows: Anof the lymphotropic papovavirus LPV (Brade et al., 1980;
initial denaturation step (5 min 1 947) was followed byTakemoto et al., 1982). This virus was isolated from a B-
39 cycles of amplification (1 min 1 947, 2 min 1 507, 1lymphoblastoid cell line from African green monkeys (zur
min 1 727) and a final elongation step of 6 min at 727.Hausen and Gissmann, 1979). Low levels of SV40-reac-
The annealing temperature of 507 was used for all primertive antibodies were detected in sera of a small propor-
combinations, except for combination I–VI (527). The en-tion of individuals who were not exposed to the SV40-
zyme was inactivated with 5 ml 0.1 M EDTA, pH 8.0. Aftercontaminated polio vaccine (Shah and Nathanson, 1976).
chloroform extraction, an aliquot of each sample wasThis positive serological reaction of humans against LPV
analyzed on a 1.5% agarose gel. Positive controls con-and SV40 not only indicates that these viruses may infect
sisted of cloned viral DNA mixed with 70 ng of humanhumans, but also points to the possible existence of
placenta DNA. Dilutions of 1, 10, 100, and 1000 DNAadditional, not yet identified human polyomaviruses.
copies/cell of each of the following polyomaviruses wereSpecific regions in the polyomavirus genome are con-
used: JCV, BKV (Gardner strain), Kilham polyomavirus,served between different members of this group (Pawlita
BFDV, LPV, mouse polyomavirus (strain a3), bovine poly-et al., 1985; Vogel et al., 1986). These include the viral
omavirus, and SV40. Negative controls consisted of reac-capsid protein VP1, as well as areas within the large-T
tion mixtures containing only water or placental DNA.antigen, a gene with transforming capacity. The present
study describes a broad-spectrum PCR method using
Southern blot analysis and hybridizationconserved regions of the polyomavirus genome with the
aim of identifying unknown human polyomaviruses that Amplified products were subjected to Southern blot
could play an etiological role in human malignancies. It analysis and hybridization was performed as previously
does not intend to prove or disprove reports on the pres- described (Shamanin et al., 1994).
ence of SV40, BKV, or JCV sequences in human tumors,
as recently described in a number of publications (Led- DNA elution and reamplification
nicky et al., 1995; de Mattei et al., 1995; Carbone et al.,
1996; Rencic et al., 1996). The total amplified DNA of the samples with positive
hybridization signals in the size range of the expected
MATERIALS AND METHODS
viral product was separated on a 1% agarose gel and
Analysis of polyomavirus genomes and primer design the DNA eluted from the gel using the Geneclean Kit
(BIO 101). In a number of cases, an aliquot of this purifiedThe following polyomaviruses were included in the
comparative analyses of the amino acid and nucleotide DNA was subjected to a second round of amplification.
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TABLE 1
Oligonucleotides Used as Primers and as Probes
Region Primer Nucleotide sequence 5*–3* Degeneracy number Polyomavirus types covered
I 1FK CWXATGTGGGARGCXAT 64 K virus
I 1FG YWXATGTGGGARGCXGT 128 General except K virus
IV 4FG GTXGGXCCXYTXTGYAA 1024 General
V 5BK GGRTAXGGRTTXGCRCA 128 K virus specific
V 5BB GGRTAXGGRTTXCKXAC 512 BFDV specific
V 5BG GGRTAXGGRTTYTTXAC 128 K virus, BFDV excluded
VI 6BG CKXACYTCYTCXACYTG 256 General
I P1 MARACXGARGTXRTXGG 2048 General
IV P4 GTXGGXCCXYTXTGYAA 1024 General
V P5 GGRTAXGGRTTYTTXAC 128 K virus, BFDV excluded
Note. M is A or C, R is A or G, W is A or T, Y is C or T, K is T or G, X is G or T or C or A. All sequences, except 6BG with 5*-TGCC, are tailed
with a BamHI-linker 5*-ttggatcc.
Cloning and sequencing acids, were obvious and therefore suitable as primers
(motif IV corresponds to nt 2195–2211 and motif VI to nt
The purified DNA was cloned using the Original TA-
2426–2442 in the JCV DNA sequence). The selection of
Cloning Kit pCR 2.1 (Invitrogen). Five to ten recombinant
two additional motifs (motifs I and V), each with four
clones of each sample were sequenced (Sequenase 2.0
identical amino acids, was based on their localization
DNA Sequencing Kit, U.S. Biochemical). The sequences
with regard to the motifs IV and VI, as well as to the
obtained were compared with the EMBL Databank and
degeneracy number of the deduced nucleotide se-
the Genbank using the HUSAR software package.
quences. These amino acid and deduced nucleotide se-
quences are shown in Fig. 1. Motif I (forward primer)Clinical samples and DNA extraction
A total of 32 biopsies from human tumors were exam-
ined. These included 15 bladder tumors, 5 Hodgkin
lymphomas, 10 meningiomas, and 2 Kaposi tumors. In
addition, 14 Kaposi-derived cell lines were analyzed. Bi-
opsies were all stored frozen at 0707 until use. DNA was
extracted as previously described (Egawa et al., 1993).
The biopsies were cut into small pieces and absolute
ethanol was added for a minimum of 3 hr. Digestion with
proteinase K and SDS was followed by phenol/chloro-
form:isoamyl alcohol extraction, after which the DNA was
ethanol precipitated.
RESULTS
The complete genomic sequences of only 9 polyomavi-
ruses (and their strains) of the 12 known types are avail-
able and therefore only these were analyzed. Nucleotide
and amino acid sequences of the genes encoding for
the viral capsid proteins VP1 and VP2, as well as the
large-T antigen, were compared among each other with
the CLUSTAL program in HUSAR. Identical amino acids
shared by all polyomaviruses were scattered throughout
these genes, but the highest level of clustering of such
identical amino acids (up to seven amino acids) occurs
within about two-thirds of the VP1 gene. In several of
FIG. 1. Alignment of the amino acid and deduced nucleotide se-
these identical areas the surrounding amino acids dif- quences for polyomaviruses in the regions of the four conserved amino
fered only in one or two polyomaviruses. Two common acid motifs. The common pattern is depicted, as are the changes spe-
cific for particular polyomavirus types.motifs (motifs IV and VI), each of six identical amino
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TABLE 2 BKV, SV40, and bovine polyomavirus and 10 copies/cell
for LPV, JCV, mouse strain a3, BFDV, and K virus. TheSensitivity of the Assay
level of detection was increased 10-fold after hybridiza-
Primer combination tion with a radiolabeled probe. A subsequent nested am-
plification led to the detection of 1 copy/cell for all viruses
Polyomavirus Regions Regions Regions tested. Each primer combination led to a characteristic
type I– V I–VI IV–VI
background pattern of amplified cellular DNA. It did not,
however, influence the detection of the viral DNA.SV40 10a/1b 10/1 1/1
LPV 100/10 100/10 10/10 The calculated melting temperatures differed consid-
JCV 10/1 100/10 10/10 erably for the sequence variations covered by each
BKV (Gardner) 10/1 10/1 1/1 primer. The lowest melting temperature for one of these
Bovine 1/1 10/10(1) 10/1
variants (within primer 5BG) was 447. This sequence vari-Mouse (a3) 10/1 100/10 10/10(1)
ation is present in the LPV DNA sequence, and thereforeBFDV 10/10 10/1 10/NDc
K virus ND 10/1 10/ND this virus was used to optimize the relation between
melting temperature and sensitivity for the degenerateProduct size (ca.) 580 bp 670 bp 250 bp
assay. Melting temperatures tested ranged from 447 to
a Sensitivity in copies per cell after ethidium bromide staining. 547. The optimal annealing temperatures (i.e., resulting
b After hybridization. in the lowest background combined with the highest sen-
c Not done. sitivity) were 507 for primer combinations 1FK/1FG–5BK/
5BB/5BG and 4FG–6BG and 527 for 1FK/1FG–6BG.
A series of 32 biopsies and 14 cell lines was subjectedcomprises the amino acids LMWEAV in seven of the
polyomavirus types. The leucine (L) in position 1 is re- to amplification with the nine primer combinations de-
scribed above. All amplified products were hybridizedplaced by a glutamine (Q) in the HaPV and mouse poly-
omaviruses. The K virus has an isoleucine (I) at position after gel electrophoresis. Despite a relatively high cellu-
lar background, any additional bands in the expected6. In the conserved motif V, VKNPYP, the amino acid
sequence of the K virus deviates in two positions. The size range were considered as possible positive signals.
The sequence homology of an unidentified member tovaline (V) at position 1 is substituted by cysteine (C) and
the lysine (K) at the second position by alanine (A). In the rest of this virus group could be extremely low, which
would result in a very faint hybridization signal despitethe BFDV genome the second amino acid is replaced by
an arginine (R). The nucleotide sequences of each motif the presence of high viral copy numbers. Therefore, sam-
ples with positive hybridization signals were eluted,were deduced from the amino acids. Degenerate primers
were designed to accommodate each nucleotide varia- cloned, and sequenced as well as reamplified in either
a nested or seminested PCR. Resulting products fromtion (Table 1). The variations present in K virus and BFDV
at the 5* and 3* ends of motifs I and V were covered by the latter amplification were cloned and a number of
clones sequenced. Nucleotide sequences were trans-the additional primers, 1FK, 5BK, and 5BB. This step was
necessary to reduce degeneracy at the 3* end to improve lated and the amino acid sequences searched for con-
served motifs. None of the sequences obtained was rem-the extension (Compton, 1990). The primers of motifs IV
and V were designed as forward and backward primers. iniscent of a polyoma viral DNA (Fig. 3).
Primers of three motifs were used in different combina-
tions for each sample to increase the possibility of de- DISCUSSION
tecting unknown polyomaviruses which could vary in
their DNA sequences in this region of VP1. The sizes of A considerable number of new papillomavirus types,
as well as herpesvirus types, have been identified andthe amplified products resulting from the primer pairs
are the following: 1FK/1FG–6BG, 670 bp; 1FK/1FG–5BK/ characterized in recent years. This led to the question
whether a similar situation exists for the polyomavirus5BB/5BG, 580 bp; 4FG–6BG, 250 bp. Three probes were
used for hybridization of the PCR products. Probes P4 family. A total of 12 polyomavirus types are known to
date. The presence of antibodies against LPV and SV40and P5 are identical to the primers 4FG and 5BG,
whereas P1 is located between motifs I and IV (JCV ge- in human sera could be indicative of the existence of
additional, yet unidentified polyomaviruses infecting hu-nome nt 1793–1809).
The detection limit for each polyomavirus type de- mans (Brade et al., 1980; Takemoto et al., 1982). The
increased sensitivity and specificity obtainable by thepended on the primer combinations used (Table 2).
Cloned viral DNA was tested against the background of use of the PCR now provides a tool to search for such
unidentified virus types. All possible sequence variationsplacental DNA. Viral dilutions were 1, 10, 100, and 1000
copies/cell (Fig. 2). The highest sensitivity obtained after covering the known DNA sequences as well as the yet
unidentified virus types can be included into degenerateethidium bromide staining varied between 1 copy/cell for
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FIG. 2. The sensitivity obtained for the following polyomavirus types using different primer combinations. Dilution series (1, 10, 100, and 1000
copies/cell each) of BKV (lanes 4–7), JCV (lanes 8–11), LPV (lanes 12–15), and SV40 (lanes 16–19) after amplification with primers 4FG–6BG (A)
and 1FG–6BG (B). Top: after ethidium bromide staining; bottom, after hybridization. Controls of water (lane 1) and human placenta DNA (lane 2)
are included. The arrows indicate the size of the expected product. M, DNA size marker.
primers. The primers described in this study were cho-
sen based on the following:
1. The highest sequence homology within a relatively
large area between known polyomavirus types: The
amino acid sequence of approximately two-thirds of the
viral capsid protein VP1 is highly conserved among the
nine polyomavirus types analyzed, confirming previous
observations (Deininger et al., 1980; Pawlita et al., 1985).
A few positions exist within the VP1 in which four to
six adjacent amino acids are identical in all the known
polyomavirus types. A much shorter amino acid stretch
within the large-T antigen is also relatively conserved,
but only one position of four identical adjacent amino
acids exists. Therefore, the degeneracy number of puta-
tive primers in this region would be much higher.
2. The lowest degree of degeneracy of each primer:
To cover all possible sequence variations, we chose to
apply primers from three motifs, rather than using one
primer pair with very high degeneracy. For the same
reason we chose to split the primers of motifs IV and V
into three different primers each, rather than increasing
the degeneracy number within one primer. A sensitivity
of at least 1 copy/cell was obtained for all polyomavirus
types tested in this assay (Fig. 2, Table 2). It should
therefore be possible to detect unknown polyomaviruses
with this method, although maybe not with the same
sensitivity.
FIG. 3. Example of the results obtained after amplification of tumor The phylogenetic analysis of the known polyomavi-
DNA with primers 1FG–5BG. Lanes 4–13: DNA from meningioma sam- ruses do not group the viruses according to closely re-
ples, lane 1: positive control (SV40 100 copies/cell), lane M: DNA size
lated host species. JCV and SV40 are grouped relativelymarker, lane 3: negative control (water), lane 2: negative control (human
close to each other (Fig. 4) and both cause PML in theirplacenta DNA). (A) After ethidium bromide staining; (B) after hybridiza-
tion. The arrow indicates the size of the expected viral product. host species (Padgett et al., 1971; Horvarth et al., 1992).
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et al., 1994) could detect these same viruses in the 94% of
the leukocyte samples from healthy adult donors. Known
polyomavirus sequences have, to our knowledge, not
been demonstrated in human lymphomas.
Herpesvirus infection induces an amplification of SV40
DNA sequences (Schlehofer et al., 1983). HHV-8 was
recently isolated from Kaposi sarcoma (Chang et al.,
1994) and a strong association of this virus as an etiologi-
cal agent has been described (Moore and Chang, 1995;
Chang et al., 1996). In our search for unidentified poly-
omaviruses, we considered the possibility that HHV-8
could have a similar amplifying effect on a polyomavirus,
if present in the lesion. Other investigators (Barbanti-
Brodano et al., 1987; Monini et al., 1996) have detected
BKV sequences in 100% of Kaposi samples tested and
JCV sequences in 11–20% of the same samples de-
pending on the type of lesion—classic, endemic, or HIV-
related. BKV was present in 75% (6/8) Kaposi-derived cell
lines, but JCV was absent in 4 of the these lines (Monini
et al., 1996). We applied our degenerate PCR method
on 14 Kaposi cell lines, but could not demonstrate any
polyomavirus sequences. The discrepancy in these re-
sults led us to reexamine our series of Kaposi cell lines
using the same primers as Monini et al. (1996), i.e.,
PYV.for and PYV.rev (Bergsagel et al., 1992). Even under
these conditions, we failed to demonstrate any poly-
omavirus sequences.
In the study described here, we have established a
degenerate PCR method that amplifies all known poly-FIG. 4. Phylogenetic tree of nine polyomavirus types (and their
omavirus types at a high sensitivity and specificity. Thisstrains), based on the partial sequence covering the conserved amino
method should also enable us to detect yet unidentifiedacid within VP1. Distance on the horizontal axis is proportional to the
similarity between sequences. polyomaviruses that could be involved in the develop-
ment of human malignancies.
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